Synthetic oligonucleotides have been used as critical research reagents in the biotechnology industry since its beginning in the 1970s. Their increasing use first led to the formation of many core ...
This episode of the Pharmaron DMPK Insights Podcast Series features Robert MacNeill (Director of Bioanalysis at Pharmaron), Professor Michael Bartlett (University Professor and Associate Dean for ...
Therapeutic oligonucleotides (ONs) offer promising treatments for conditions beyond what traditional therapies can target. As a new class of molecules, they demand precise characterization in both ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback